BISOPROLOL IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper compares the efficacy of bisoprolol and other β-adrenoblockers in the therapy of major cardiovascular diseases and gives data on the therapeutic equivalence of Bidop to original bisopropol.

Full Text

Restricted Access

About the authors

A. Shavarov

Email: shavarov@yahoo.com

References

  1. Cruickshank J.M. Evolving strategies for optimal care management and plan benefit designs // Am. J. Manag. Care. - 2012; 18(10): 228-33.
  2. Bristow M. Beta-adrenergic receptor blockade in chronic heart failure // Circulation. - 2000; 101: 558-69.
  3. Metra M., Nodari S., D’Aloia A. et al. Beta blockers in heart failure: issues in the management of individual patients // Heart Fail. Rev. - 1999; 4: 65-77.
  4. Sirak T.E., Jelic S., Le Jemtel T.H. Therapeutic update: non-selective beta-and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure // J. Am. Coll. Cardiol. - 2004; 44: 497-502.
  5. Le Jemtel T.H., Padeletti M., Jelic S. Diagnostic and therapeutic chal- lenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure // J. Am. Coll. Cardiol. - 2007; 49: 171-80.
  6. Leopold G., Kutz K. Bisoprolol: pharmacokinetic profile // Rev. Contemp. Pharmacother. - 1997; 8: 35-43.
  7. Stoschitzky K., Stoschitzky G., Klein W. et al. Different effects of exercise on plasma concentrations of nebivolol, bisoprolol and carvedilol // Cardiovasc. Drugs Ther. - 2004; 18: 135-138.
  8. Cruickshank J.M. The modern role of beta-blockers in cardiovascular medicine // People’s Medical Publishing House. USA, Shelton, Connecticut. - 2011; 271 p.
  9. Opie L.H., Gersh B.J. Drugs for the Heart // 7th Edition. Elsevier. - 2009; 512 p.
  10. Agostoni P., Contini M., Cattadori G. et al. Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant? // Eur. J. Heart Fail. -2007; 9(8): 827-33.
  11. Беленков Ю.Н., Скворцов А.А., Мареев В.Ю. и др. Клинико-гемодинамические и нейрогормональные эффекты длительной терапии β-адреноблокатором бисопрололом у больных с тяжелой хронической сердечной недостаточностью // Кардиология. -2003; 10: 10-23.
  12. Kjeksus J.K., Gilpin E., Cali G. et al. Diabetic patients and beta-blockers after acute myocardial infarction // Eur. Heart J. - 1990; 11: 43-50.
  13. Chen J., Marciniac T.A., Radford M.J. et al. Beta-blockers therapy for secondary prevention of myocardial infarction in elderly diabetic patients // JACC. -1999; 34: 1388-94.
  14. Ohtsuka T., Hamada M., Hiasa G. et al. Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy // J. Am. Coll. Cardiol. - 2001; 37:412-7.
  15. von Haehling S., Genth-Zotz S., Bolger A.P. et al. Effect of noradrenaline and isoproterenol on lipopolysaccharide-induced tumor necrosis factor-alpha production in whole blood from patients with chronic heart failure and the role of beta-adrenergic receptors // Am. J. Cardiol. - 2005; 95: 885-9.
  16. Ichihara S., Yamada Y., Ichihara G. et al. Attenuation of oxidative stress and cardiac dysfunction by bisoprolol in an animal model of dilated cardiomyopathy // Biochem. Biophys. Res. Commun. - 2006; 350: 105-13.
  17. Dubach P., Myers J., Bonetti P. et al. Effects of bisoprolol fumarate on left ventricular size, function, and exercise capacity in patents with heart failure: analysis with magnetic resonance myocardial tagging // Am. Heart. J. - 2002; 143: 676-83.
  18. Metra M., Giubbini R., Nodari S. et al. Differential effects of β-blockers in patients with heart failure. A prospective, double-blind comparison of the long-term effects of metoprolol versus carvedilol // Circulation. - 2000; 102: 546-51.
  19. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study: a randomised trial // Lancet. - 1999; 353: 9-13.
  20. Willenheimer R., Van Veldhuisen D.J., Silke B. et al. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence. Results of the Randomized Cardiac Insuffi ciency Bisoprolol Study (CIBIS) III // Circulation. -2005; 112: 2426-35.
  21. Flather M.D., Shibata M.C., Coats A.J.S. et al. Randomised trial to determine the effect of nebivolol on mortality and hospital admission in elderly patients with heart failure (SENIORS) // Eur. Heart J. - 2005; 26: 215-25.
  22. Food and Drug Administration. Meeting of the Cardiovascular and Renal Drugs Advisory Committee, Jan. 11, 2010.
  23. Stoschitzky K., Stoschitzky G., Brussee H. et al. Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol // Cardiology. - 2006; 106(4): 199-206.
  24. Lopez-Sendon J., Swedberg K., McMurray J. et al. Expert consensus document on b-adrenergic receptor blockers. The Task Force on Beta-Blockers of the European Society of Cardiology //. Eur. Heart J. - 2004; 25: 1341-62.
  25. Weber F., Schneider H., von Arnim T., Urbaszek W. Heart rate variability and ischaemia in patients with coronary heart disease and stable angina pectoris; influence of drug therapy and prognostic value. TIBBS Investigators Group. Total Ischemic Burden Bisoprolol Study // Eur. Heart J. - 1999; 20 (1): 38-50.
  26. Steilaty G., Madi-Jebara S., Yazigi A. et al. Postoperative oral amiodarone versus oral bisoprolol as prophylaxis against atrial fibrillation after coronary bypass graft surgery: a prospective randomized trial // Int. J. Cardiol. - 2009; 117 (2): 116-22.
  27. Plewan A., Alt E. Current status of internal cardioversion in atrial fibrillation // Indian Pacing Electrophysiol. J. - 2002; 2 (2): 40-4.
  28. Czuriga I., Riecansky I., Bodnar J. et al. Comparison of the new cardioselective beta-blocker nebivolol with bisoprolol in hypertension: the Nebivolol, Bisoprolol Multicenter Study (NEBIS) // Cardiovasc. Drugs Ther. - 2003; 17 (3): 257-63.
  29. Breed J.G., Ciampricotti R., Tromp G.P. et al. Quality of life perception during antihypertensive treatment: a comparative study of bisoprolol and enalapril // J. Cardiovasc. Pharmacol. - 1992; 20 (5): 750-5.
  30. Bueno J., Amiguet J.A., Carasusan J. et al. Bisoprolol vs. chlorthalidone: a randomized, double-blind, comparative study in arterial hypertension // J. Cardiovasc. Pharmacol. - 1990; 16 (5): 189-92.
  31. Olivan Martinez J., Garcia M.J., Rodriguez Botaro A. et al. Bisoprolol and nifedipine SR in the treatment of hypertension in the elderly // J. Cardiovasc. Pharmacol. - 1990; 16 (5): 95-9.
  32. Haasis R., Bethge H. Exercise blood pressure and heart rate reduction 24 and 3 hours after drug intake in hypertensive patients following 4 weeks оf treatment with bisoprolol and metoprolol: a randomized multicentre double-blind study (BISOMET) // Eur. Heart J. - 1987; 8: 103-13.
  33. Fagard R.H., Celis H., Thijs L. et al. Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies // Hypertension. - 2009; 54 (5): 1084-91.
  34. Parrinello G., Di Pasquale P., Torres D. et al. One-year renal and cardiac effects of bisoprolol versus losartan in recently diagnosed hypertensive patients: a randomized, double-blind study // Clin. Drug Invest. - 2009; 29: 591-600.
  35. Stefanadis C., Dernellis J.J., Siamis E. et al. Aortic stiffness as a risk factor for recurrent acute coronary events in patients with ischaemic heart disease // Eur. Heart J. - 2001; 22: 181.
  36. Blacher J., Pannier B., Guerin A.P. et al. Carotid arterial stiffness as predictor of cardiovascular and all-cause mortality in end-stage renal disease // Hypertension. - 1998; 32: 570-4.
  37. Asmar R., Kerihuel J.C., Girerd X.J. et al. Effect of bisoprolol on blood pressure and arterial hemodynamics in systemic hypertension // Am. J. Cardiol. -1991; 68: 61-4.
  38. Barenbrock M. Effect of lisinopril and metoprolol on arterial distensibility //. Hypertension. - 1994; 24: 161-3.
  39. Poldermans D., Boersma E., Bax J.J. et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery // N. Engl. J. Med. - 1999; 341:1789-94.
  40. Powell J.T. Perioperative β-blockade (Pobble) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial // J. Vas. Surg. - 2005; 41: 602-9.
  41. Протасов К.В., Дзизинский А.А., Шевченко О.П. и др. Антиангинальная и антигипертензивная эффективность бисопролола: сравнение генерика бидоп с оригинальным препаратом // Фарматека. - 2012; 17: 57-63.
  42. Mancia G., De Backer G., Dominiczak A. et al. Task force for the management of arterial hypertension of the European Society of Hypertension; Task force for the management of arterial hypertension of the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) // Eur. Heart J. - 2007; 28 (12):1462-536.
  43. Steg P.G., James S.K., Atar D. et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC) // Eur. Heart J. - 2012; 33 (20): 2569-619.
  44. Hamm C.W., Bassand J.P., Agewall S. et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) // G. Ital. Cardiol. - 2012; 13 (3): 171-228.
  45. McMurray J.J., Adamopoulos S., Anker S.D. et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC // Eur. J. Heart Fail. - 2012; 14 (8): 803-69.
  46. Zipes D.P., Camm A.J., Borggrefe M. et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society // Circulation. - 2006; 114: 385-484.
  47. Freemantle N., Cleland J., Young P. et al. Beta blockade after myocardial infarction: systematic review and meta regression analysis // BMJ. - 1999; 318: 1730-37.
  48. Fox K., Garcia M.A., Ardissino D. et al. Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology // Eur. Heart J. - 2006; 27 (11): 1341-81.
  49. Lindholm L.H., Carlberg B., Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis // Lancet. -2005; 366: 1545-53.
  50. Wiysonge C.S., Bradley H., Mayosi B.M. et al. Betablockers for hypertension // Cochrane Database Syst. Rev. - 2007; 1: CD002003.
  51. Nice website. The clinical management of primary hypertension in adults. Accessed Dec. 3, 2011. http://www.nice.org.uk/guidance/index. jsp?action=download&o=53228.
  52. National Collaborating Centre for Chronic Conditions. Hypertension: Management of Hypertension in Adults in Primary Care: Partial Update // London, England: Royal College of Physicians; 2006.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies